Somalia launches pentavalent vaccine with support from GAVI, UNICEF, WHO

Published on April 30, 2013 at 7:50 AM · No Comments

"Coinciding with World Immunization Week, the Somali government announced on 24 April its intention to vaccinate all children under the age of one with a new five-in-one vaccine, known as a pentavalent vaccine, funded by the GAVI Alliance, with [UNICEF] and the [WHO] as implementing partners," IRIN reports. "Currently, fewer than half of children in Somalia have received the mandatory diphtheria, tetanus and pertussis (DTP) vaccine," but "[t]he pentavalent will protect immunized children against these three diseases, as well as hepatitis B and Haemophilius influenzae type B," according to the news service (4/26). "President Hassan Sheikh Mohamud, speaking at the new vaccine's launch in Mogadishu on Wednesday, said all Somali children deserve the good health that children from rich countries enjoy," Bloomberg Businessweek writes, adding, "He blamed much of the country's vaccination problem on al-Shabab, the al-Qaida-linked militant group that controls much of south-central Somalia and up until August 2011 controlled Mogadishu" (Straziuso, 4/25). A GAVI Alliance press release notes, "The launch of the vaccine is being accompanied by an outreach campaign to make parents aware of the importance of the new vaccine which replaces the DTP vaccine for diphtheria, tetanus and pertussis (whooping cough)" (4/23).

http://www.kaiserhealthnews.orgThis article was reprinted from with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
Patient-specific immunotherapeutic vaccines may improve overall survival of melanoma patients